SCHEMBL17829893

SCHEMBL17829893

Cc1cccc2c(NCCCN(C)C)nc(-c3ccc(-c4cc(F)cc(C(F)(F)F)c4)cc3)nc12

nearest known ligand 0.49

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
RAD52 P43351 4/20 0.49
ALDH1A1 P00352 2/20 0.47
MAPK1 P28482 1/20 0.47
KMT2A Q03164 2/20 0.46
POLB P06746 3/20 0.46
RXFP1 Q9HBX9 1/20 0.44
TLR9 Q9NR96 1/20 0.43
KCNH2 Q12809 1/20 0.42
SMARCA2 P51531 1/20 0.42
FLT3 P36888 3/20 0.41
KDM4E B2RXH2 1/20 0.38
TSHR P16473 1/20 0.38
HSD17B10 Q99714 1/20 0.38
TDP1 Q9NUW8 1/20 0.38
SYK P43405 1/20 0.38
MEN1 O00255 1/20 0.38
TRIM58 Q8NG06 2/20 0.37
KDR P35968 1/20 0.37
TOP2A P11388 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17829875 0.95 RAD52 (0.48) RAD52ALDH1A1MAPK1KMT2APOLB
SCHEMBL17829841 0.94 RAD52 (0.50) RAD52ALDH1A1MAPK1KMT2APOLB
SCHEMBL17829844 0.91 RAD52 (0.48) RAD52ALDH1A1MAPK1KMT2APOLB
SCHEMBL17829872 0.90 RAD52 (0.52) RAD52ALDH1A1MAPK1KMT2APOLB
SCHEMBL17829576 0.89 RAD52 (0.55) RAD52ALDH1A1MAPK1KMT2APOLB
SCHEMBL17829850 0.88 RAD52 (0.47) RAD52ALDH1A1MAPK1KMT2APOLB
SCHEMBL17829877 0.88 RAD52 (0.46) RAD52ALDH1A1MAPK1KMT2APOLB
SCHEMBL17829839 0.87 RAD52 (0.50) RAD52ALDH1A1MAPK1KMT2APOLB
SCHEMBL17829573 0.87 RAD52 (0.54) RAD52ALDH1A1MAPK1KMT2APOLB
SCHEMBL17829859 0.87 RAD52 (0.56) RAD52ALDH1A1MAPK1KMT2APOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20160168140-A1 HETEROCYCLIC COMPOUNDS AS ANTIBIOTIC POTENTIATORS SYNERECA PHARMACEUTICALS (US) 2016-06-16 US disclosed
US-20160168140-A1 HETEROCYCLIC COMPOUNDS AS ANTIBIOTIC POTENTIATORS SYNERECA PHARMACEUTICALS (US) 2016-06-16 US disclosed
WO-2016094730-A1 HETEROCYCLIC COMPOUNDS AS ANTIBIOTIC POTENTIATORS SYNERECA PHARMACEUTICALS, INC. (US) 2016-06-16 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160168140-A1 HETEROCYCLIC COMPOUNDS AS ANTIBIOTIC POTENTIATORS FOS, FOSB, YAP1 RAD52 1940/4885ALDH1A1 4840/4885MAPK1 192/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.